0
July 14, 1962, Vol 181, No. 2 >
ARTICLE | July 14, 1962

A Five-Year Study of Tolbutamide in the Treatment of Diabetes Mellitus

DeWitt E. DeLawter, M.D.; James M. Moss, M.D.
JAMA. 1962;181(2):156-158. doi:10.1001/jama.1962.03050280086013.
Text Size: A A A
Published online
Article
References

THE ULTIMATE value of the sulfonylurea drugs in the management of the mild "adult type" diabetic is being determined by the accumulation of results in patients taking the drugs over a long period of time. The 5-year follow-up of 200 patients who started taking tolbutamide in 1956, is reviewed for evaluation of the effectiveness of this sulfonylurea preparation. This group has been reported previously after 12, 24, and 36 months of treatment.

Method

The 200 patients selected for this study consisted of 105 treated in the Diabetic Clinic of the Georgetown University Hospital and 95 treated in our private offices. All were instructed to follow a measured diet, but it was obvious that many of them made no change in their food habits. Tolbutamide (Orinase) was used in the smallest effective dose. The tolbutamide response test was not used in the selection of our patients, but the drug was offered to

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Letters

Submit a Letter
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs

More Listings at
JAMACareerCenter.com >

© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems